103 related articles for article (PubMed ID: 15980694)
1. Nonfinancial factors associated with decreased plasma viral load testing in Ontario, Canada.
Raboud JM; Abdurrahman ZB; Major C; Millson P; Robinson G; Rachlis A; Bayoumi AM
J Acquir Immune Defic Syndr; 2005 Jul; 39(3):327-32. PubMed ID: 15980694
[TBL] [Abstract][Full Text] [Related]
2. Regional differences in rates of HIV-1 viral load monitoring in Canada: Insights and implications for antiretroviral care in high income countries.
Raboud JM; Loutfy MR; Su D; Bayoumi AM; Klein MB; Cooper C; Machouf N; Rourke S; Walmsley S; Rachlis A; Harrigan PR; Smieja M; Tsoukas C; Montaner JS; Hogg RS;
BMC Infect Dis; 2010 Feb; 10():40. PubMed ID: 20184766
[TBL] [Abstract][Full Text] [Related]
3. Detection and quantification of proviral HIV-1 184 M/V in circulating CD4(+) T cells of patients on HAART with a viremia less than 1,000 copies/ml.
Mohey R; Jørgensen LB; Møller BK; Black FT; Kjems J; Obel N
J Clin Virol; 2005 Dec; 34(4):257-67. PubMed ID: 16286049
[TBL] [Abstract][Full Text] [Related]
4. Social determinants of health and retention in HIV care in a clinical cohort in Ontario, Canada.
Rachlis B; Burchell AN; Gardner S; Light L; Raboud J; Antoniou T; Bacon J; Benoit A; Cooper C; Kendall C; Loutfy M; Wobeser W; McGee F; Rachlis A; Rourke SB;
AIDS Care; 2017 Jul; 29(7):828-837. PubMed ID: 28027668
[TBL] [Abstract][Full Text] [Related]
5. HIV-1 second-line failure and drug resistance at high-level and low-level viremia in Western Kenya.
Kantor R; DeLong A; Schreier L; Reitsma M; Kemboi E; Orido M; Obonge S; Boinett R; Rono M; Emonyi W; Brooks K; Coetzer M; Buziba N; Hogan J; Diero L
AIDS; 2018 Nov; 32(17):2485-2496. PubMed ID: 30134290
[TBL] [Abstract][Full Text] [Related]
6. CD4 count-based failure criteria combined with viral load monitoring may trigger worse switch decisions than viral load monitoring alone.
Hoffmann CJ; Maritz J; van Zyl GU
Trop Med Int Health; 2016 Feb; 21(2):219-23. PubMed ID: 26584666
[TBL] [Abstract][Full Text] [Related]
7. Implementation and Operational Research: Engagement in HIV Care Among Persons Enrolled in a Clinical HIV Cohort in Ontario, Canada, 2001-2011.
Burchell AN; Gardner S; Light L; Ellis BM; Antoniou T; Bacon J; Benoit A; Cooper C; Kendall C; Loutfy M; McGee F; Raboud J; Rachlis A; Wobeser W; Rourke SB
J Acquir Immune Defic Syndr; 2015 Sep; 70(1):e10-9. PubMed ID: 26322672
[TBL] [Abstract][Full Text] [Related]
8. Estimated average annual rate of change of CD4(+) T-cell counts in patients on combination antiretroviral therapy.
Mocroft A; Phillips AN; Ledergerber B; Smith C; Bogner JR; Lacombe K; Wiercinska-Drapalo A; Reiss P; Kirk O; Lundgren JD;
Antivir Ther; 2010; 15(4):563-70. PubMed ID: 20587849
[TBL] [Abstract][Full Text] [Related]
9. Impact of HIV-1 Subtype on the Time to CD4+ T-Cell Recovery in Combination Antiretroviral Therapy (cART)-Experienced Patients.
Chow WZ; Lim SH; Ong LY; Yong YK; Takebe Y; Kamarulzaman A; Tee KK
PLoS One; 2015; 10(9):e0137281. PubMed ID: 26335136
[TBL] [Abstract][Full Text] [Related]
10. Assessment of antiretroviral therapy by plasma viral load testing: standard and ICD HIV-1 p24 antigen and viral RNA (QC-PCR) assays compared.
Kappes JC; Saag MS; Shaw GM; Hahn BH; Chopra P; Chen S; Emini EA; McFarland R; Yang LC; Piatak M
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Oct; 10(2):139-49. PubMed ID: 7552477
[TBL] [Abstract][Full Text] [Related]
11. A randomized study comparing triple versus double antiretroviral therapy or no treatment in HIV-1-infected patients in very early stage disease: the Spanish Earth-1 study.
García F; Romeu J; Grau I; Sambeat MA; Dalmau D; Knobel H; Gomez-Sirvent JL; Arrizabalaga J; Cruceta A; Clotet BG; Podzamczer D; Pumarola T; Gallart T; O'Brien WA; Miró JM; Gatell JM
AIDS; 1999 Dec; 13(17):2377-88. PubMed ID: 10597779
[TBL] [Abstract][Full Text] [Related]
12. Impact of drug resistance genotypes on CD4+ counts and plasma viremia in heavily antiretroviral-experienced HIV-infected patients.
Rodes B; García F; Gutierrez C; Martinez-Picado J; Aguilera A; Saumoy M; Vallejo A; Domingo P; Dalmau D; Ribas MA; Blanco JL; Pedreira J; Perez-Elias MJ; Leal M; de Mendoza C; Soriano V;
J Med Virol; 2005 Sep; 77(1):23-8. PubMed ID: 16032728
[TBL] [Abstract][Full Text] [Related]
13. Pre-HAART HIV burden approximates post-HAART viral levels following interruption of therapy in patients with sustained viral suppression.
Hatano H; Vogel S; Yoder C; Metcalf JA; Dewar R; Davey RT; Polis MA
AIDS; 2000 Jul; 14(10):1357-63. PubMed ID: 10930150
[TBL] [Abstract][Full Text] [Related]
14. Decreased adherence to antiretroviral therapy observed prior to transient human immunodeficiency virus type 1 viremia.
Podsadecki TJ; Vrijens BC; Tousset EP; Rode RA; Hanna GJ
J Infect Dis; 2007 Dec; 196(12):1773-8. PubMed ID: 18190257
[TBL] [Abstract][Full Text] [Related]
15. High retention in HIV care at a tertiary care centre in Toronto, Canada.
Szadkowski L; Walmsley S; Burchell AN; Collins E; Rourke SB; Raboud J;
AIDS Care; 2018 Feb; 30(2):246-254. PubMed ID: 28678619
[TBL] [Abstract][Full Text] [Related]
16. Factors associated with high-risk low-level viremia leading to virologic failure: 16-year retrospective study of a Chinese antiretroviral therapy cohort.
Zhang T; Ding H; An M; Wang X; Tian W; Zhao B; Han X
BMC Infect Dis; 2020 Feb; 20(1):147. PubMed ID: 32066392
[TBL] [Abstract][Full Text] [Related]
17. Characterizing Patients with Very-Low-Level HIV Viremia: A Community-Based Study.
Helou E; Shenoi S; Kyriakides T; Landry ML; Kozal M; Barakat LA
J Int Assoc Provid AIDS Care; 2017; 16(3):261-266. PubMed ID: 27903948
[TBL] [Abstract][Full Text] [Related]
18. HIV-1 drug resistance profiles in children and adults with viral load of <50 copies/ml receiving combination therapy.
Hermankova M; Ray SC; Ruff C; Powell-Davis M; Ingersoll R; D'Aquila RT; Quinn TC; Siliciano JD; Siliciano RF; Persaud D
JAMA; 2001 Jul; 286(2):196-207. PubMed ID: 11448283
[TBL] [Abstract][Full Text] [Related]
19. The dual-target approach in viral HIV-1 viremia testing: An added value to virological monitoring?
Amendola A; Sberna G; Forbici F; Abbate I; Lorenzini P; Pinnetti C; Antinori A; Capobianchi MR
PLoS One; 2020; 15(2):e0228192. PubMed ID: 32023284
[TBL] [Abstract][Full Text] [Related]
20. Assessing Antiretroviral Use During Gaps in HIV Primary Care Using Multisite Medicaid Claims and Clinical Data.
Monroe AK; Fleishman JA; Voss CC; Keruly JC; Nijhawan AE; Agwu AL; Aberg JA; Rutstein RM; Moore RD; Gebo KA;
J Acquir Immune Defic Syndr; 2017 Sep; 76(1):82-89. PubMed ID: 28797023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
